Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amanda M. Lulu"'
Autor:
Victor H. Engelhard, Susan C. Modesitt, Craig L. Slingluff, Kimberly A. Chianese-Bullock, Rachel M. Lacy, Dennis Underwood, Paisley T. Myers, Erin D. Jeffery, Kara L. Cummings, Amanda M. Lulu
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c83d943b3bb9a7554758c8a99b417e8
https://doi.org/10.1158/2326-6066.22544321
https://doi.org/10.1158/2326-6066.22544321
Autor:
Victor H. Engelhard, Susan C. Modesitt, Craig L. Slingluff, Kimberly A. Chianese-Bullock, Rachel M. Lacy, Dennis Underwood, Paisley T. Myers, Erin D. Jeffery, Kara L. Cummings, Amanda M. Lulu
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41443a4dfaeff7deafd597073f50505d
https://doi.org/10.1158/2326-6066.22544318
https://doi.org/10.1158/2326-6066.22544318
Autor:
Victor H. Engelhard, Susan C. Modesitt, Craig L. Slingluff, Kimberly A. Chianese-Bullock, Rachel M. Lacy, Dennis Underwood, Paisley T. Myers, Erin D. Jeffery, Kara L. Cummings, Amanda M. Lulu
Elevated immunity to cancer-expressed antigens can be detected in people with no history of cancer and may contribute to cancer prevention. We have previously reported that MHC-restricted phosphopeptides are cancer-expressed antigens and targets of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1894dd2024e081cafdc34ad4e6a78c3
https://doi.org/10.1158/2326-6066.c.6550604
https://doi.org/10.1158/2326-6066.c.6550604
Autor:
Kimberly A. Chianese-Bullock, Craig L. Slingluff, Susan C. Modesitt, Victor H. Engelhard, Kara L. Cummings, Rachel M Lacy, Paisley T. Myers, Erin D. Jeffery, Amanda M. Lulu, Dennis J. Underwood
Publikováno v:
Cancer Immunol Res
Elevated immunity to cancer-expressed antigens can be detected in people with no history of cancer and may contribute to cancer prevention. We have previously reported that MHC-restricted phosphopeptides are cancer-expressed antigens and targets of i
Autor:
Rebecca C. Obeng, Nikole Varhegyi, Kimberly A. Chianese-Bullock, Gina R. Petroni, Geoffrey R. Weiss, Elizabeth M. Gaughan, Angela L. Ambakhutwala, Emily H. Hall, Kelly T. Smith, Mark Cobbold, Victor H. Engelhard, Kara L. Cummings, Amanda M. Lulu, Paisley T. Myers, Mark E. Smolkin, Nico Buettner, Craig L. Slingluff, Jeffrey Shabanowitz, Kathleen Haden, Donald F. Hunt, Keira E. Mahoney
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundPhosphorylated peptides presented by MHC molecules represent a new class of neoantigens expressed on cancer cells and recognized by CD8 T-cells. These peptides are promising targets for cancer immunotherapy. Previous work identified an HLA-
Publikováno v:
The Journal of Immunology. 204:242.54-242.54
Dysregulated protein phosphorylation plays a major role in cancer cell malignancy. We showed that phosphopeptides are presented by MHC-I molecules, representing a new class of cancer neoantigens. We found that healthy donors with no evident prior can
Publikováno v:
Cancer Immunology Research. 8:B68-B68
Identifying appropriate antigens is essential to developing effective cancer vaccines. Protein phosphorylation plays a major role in signal transduction pathways that are dysregulated and contribute to the malignant phenotype of cancer cells. Our lab